U
CBM

UBS’s Cambrex Corporation CBM Stock Holding History

UBS’s Portfolio CBM Stock Details CBM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-100
Closed -$2K – 11019
2014
Q1 		$2K Buy
+100
New +$1.93K ﹤0.01% 10094

Other funds holding CBM

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

UBS's CBM Position: Q3 2014 in Review

UBS reduced its Cambrex Corporation (CBM) stake by 79% in Q3 2014, selling an estimated $69.4K and leaving 868 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #8304.

UBS first reported a position in CBM in Q2 2013 and has held it in 6 quarters since. The position peaked at $516K in Q2 2013. 172 funds tracked by Wall St. Rank hold CBM as of Q3 2014.

  • UBS held 868 shares of Cambrex Corporation worth $16K as of Q3 2014.
  • UBS sold 3,232 Cambrex Corporation shares in Q3 2014, an estimated $69.4K.
  • Cambrex Corporation made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8304 holding.
  • UBS first reported a position in Cambrex Corporation in Q2 2013 and has held it in 6 quarters since.
  • UBS's Cambrex Corporation position peaked at $516K in Q2 2013.
  • 172 funds tracked by Wall St. Rank held Cambrex Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.